1Pauwels R A,Buist A S,Calverley P M,et al.Global strategy for the diagnosis,management,and prevention of chronic obstructive pulmonary disease.NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary[J].Am J Respir Crit Care Med,2001,163(5):1256. 被引量：1
2Renkema T E,Schouten J P,Koeter G H,et al.Effects of long-term treatment with corticosteroids in COPD[J].Chest,1996,109(5):1156. 被引量：1
3Maltais F,Ostinelli J,Bourbeau J,et al.Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease:a randomized controlled trial[J].Am J Respir Crit Care Med,2002,165(5):698. 被引量：1
4Oudijk E J,Lammers J W,Koenderman L.Systemic inflammation in chronic obstructive pulmonary disease[J].Eur Respir J,2003,46(11):5. 被引量：1
5Niewoehner D E,Erbland M L,Deupree R H,et al.Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease[J].N Engl J Med,1999,340(25):1941. 被引量：1
6Davies L,Angus R M,Calverley P M A.Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease:a prospective randomized controlled trial[J].Lancet,1999,354(9177):456. 被引量：1
7Osman L M,Godden D J,Friend J A R,et al.Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease[J].Thorax,1999,52(1):67. 被引量：1
8Decramer M,Gosselink R,Troosters T,et al.Muscle weakness is related to utilization of health care resources in COPD patients[J].Eur Respir J,1997,10(2):417. 被引量：1
9McEvoy C E,Ensrud K E,Bender E,et al.Association between corticosteroid use and vertebral fractures in older men with chronic obstructive pulmonary disease[J].Am J Respir Crit Care Med,1998,157(3):704. 被引量：1
10Johnell O,Pauwels R,Lofdahl C G,et al.Bone mineral density in patients with chronic obstructive pulmonary disease treated with budesonide Turbuhaler[J].Eur Respir J,2002,19(6):1058. 被引量：1
8Maltais F,Ostinelli J,Bourbeau J,et al.Comparison of nebulized budesonide and oral prextnisolonc with placebo in the treatment of acute exacerbations of chronic obs-'uctive pulmonary disease:a randomized contzolled trial.[J].Am J Rcspir Crit Care Mad,2002, 165:698-703. 被引量：1
9Rohde G,Gevaert P, Hohappels G,et al.Soluble interleukin-5 receptor alpha is increased in acute exacerbation of chronic obstructive pulmonary disease [J].Int Arch Allergy ImmunoI,2004,135:54--61. 被引量：1
10J ANSSON A H, ERIKSSON C, WANG X, et al. Effects of budesonide and N-acetylcysteine on acute lung hyperinflation, inflammation and injury in rats [J]. Vascul Pharmacol, 2005,43 : 101 - 111. 被引量：1
